GoldenGolden
Advanced Search
E25Bio

E25Bio

Medical diagnostics company developing diagnostic tests for fever syndromes and infectious diseases

E25Bio develops Rapid Diagnostic Tests for fever syndromes which account for over 1 billion episodes annually and are one of the most common reasons to seek care worldwide . The company is working on rapid diagnosis of diseases such as dengue, zika and COVID-19. E25VBio’s diagnostic tests use nanoparticle technology to capture virus or viral proteins that are secreted in the body based on technology developed by Irene Bosch and Lee Gehrke, the Hermann von Helmholtz Professor of Health Sciences and Technology at MIT.

The company’s COVID-19 test is similar to a pregnancy test and it has received $2 million from Khosla Ventures which will fund research and development, clinical studies and scaling launch of diagnostic tests once FDA Emergency Use Approval (EUA) approval is received.

Timeline

2018
E25Bio was founded by Bobby Brooke Herrera, Irene Bosch and Lee Gehrke.

Funding rounds

People

Name
Role
LinkedIn

Bobby Brooke Herrera

Co-Founder, CEO

Irene Bosch

Founder, CEO

Further reading

Title
Author
Link
Type
Date

A comparison of nanoparticle-antibody conjugation strategies in sandwich immunoassays. - PubMed - NCBI

pubmeddev, Tam JO , et al.

Web

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. - PubMed - NCBI

pubmeddev, Bosch I , et al.

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Carolyn Barber
August 21, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.